• Home
  • NEW DAY MEDICINE
  • 8 (46) 2022
  • 20 –8 (46) 2022 — Tukhtabaev A.A. — DOPPLER STUDY OF UTERINE AND PLACENTAL BLOOD FLOW IN PREGNANT WOMEN WITH COVID-19 ASSOCIATED MYOCARDITIS

20 –8 (46) 2022 — Tukhtabaev A.A. — DOPPLER STUDY OF UTERINE AND PLACENTAL BLOOD FLOW IN PREGNANT WOMEN WITH COVID-19 ASSOCIATED MYOCARDITIS

DOPPLER STUDY OF UTERINE AND PLACENTAL BLOOD FLOW IN PREGNANT WOMEN WITH COVID-19 ASSOCIATED MYOCARDITIS

Tukhtabaev A.A. Republican Specialized Scientific and Practical Medical Center for Obstetrics and Gynecology of the Ministry of Health of the Republic of Uzbekistan, Tashkent

Resume

In 2019, the entire population faced a new viral disease COVID-19 (SARS-Cov-2), which occurs with many complications. We have analyzed all scientific reports on the prevalence of myocarditis during COVID-19, but the data of the authors fluctuate widely. Very often, myocarditis is overlooked under the guise of other diseases, and is not diagnosed. At the onset of fatal cases, myocarditis was not clinically suspected, included in the diagnosis, or listed as a possible cause of death. IHD, acute myocardial infarction appeared as erroneous diagnoses that did not receive confirmation at autopsy. A morphological study of heart preparations revealed a pattern of lymphocytic myocarditis that met the Dallas criteria for diagnosis. [2]. Myocarditis significantly leads to deterioration of blood flow in the fetoplacental complex.

Keywords: myocarditis, myocarditis during pregnancy, COVID-19 associated myocarditis, fetoplacental dysfunction.

First page

110

Last page

114

For citation: Tukhtabaev A.A. DOPPLER STUDY OF UTERINE AND PLACENTAL BLOOD FLOW IN PREGNANT WOMEN WITH COVID-19 ASSOCIATED MYOCARDITIS //New Day in Medicine 8(46)2022 110-114 https://clck.ru/sWm2x

LIST OF REFERENCES:

  1. Bansal M. Cardiovascular Disease and COVID-19 // Diabetes & Metabolic Syndrome: Clinical Research & Reviews. ― 2020. ― Vol. 14. ― P. 247-250
  2. Коган Е.А.,   Березовский Ю.С.,   Благова О.В. Миокардит у пациентов с COVID-19, подтвержденный результатами иммуногистохимического исследования // Кардиология журнал// Том 60, № 7 (2020) doi.org/10.18087/cardio.2020.7.n1209
  3. Lippi G., M Henry M.B. and Sanchis-Gomar F. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19) // European Journal of Preventive Cardiology. The European Society of Cardiology. ― 2020 ― 0(0). ― P. 1-3
  4. Hulot J.S. COVID-19 in patients with cardiovascular diseases // Arch Cardiovasc Dis. ― 2020. ― S1875-2136(20)30080-2. 3. Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system // Nat Rev Cardiol. ― 2020. ― 10.1038/ s41569-020-0360-5
  5. Chan J.F., Kok K.H., Zhu Z. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan // Emerg Microbes Infect. ― 2020.
  6. Tan W., Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease // Int J Cardiol. ― 2020. ― S0167-5273(20)31593-X.
  7. Lippi G., Lavie C.J., Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis [published online] // Prog Cardiovasc Dis [published online]. ― 2020

file

download